Open access peer-reviewed chapter

In Vitro Fertilization Activators for Future

Written By

Hiromitsu Tanaka, Morimasa Wada, Nguyen Huu Tung, Shunsuke Fujii, Takuhiro Uto and Yukihiro Shoyama

Submitted: 29 June 2016 Reviewed: 13 October 2016 Published: 03 May 2017

DOI: 10.5772/66317

From the Edited Volume

Biological Activities and Action Mechanisms of Licorice Ingredients

Edited by Hiroshi Sakagami

Chapter metrics overview

1,635 Chapter Downloads

View Full Metrics

Abstract

Artificial insemination is an indispensable technology for cattle breeding and is used for treating infertility in humans. Thus, new or improved methods are needed to increase the efficiency of artificial insemination. In vitro fertilization (IVF) has been developed in mice. Although many mouse lines produced using IVF have been preserved by freezing embryos and/or fertilized eggs, the more efficient IVF using freezing preservation or long‐term refrigeration of sperm is expected to preserve mouse lines more easily. In this chapter, we introduce the active compounds in licorice to improve the rate of IVF. We previously reported that the rate of IVF in mice was improved by adding a water extract of licorice (Glycyrrhiza uralensis), but not glycyrrhizin, to the artificial insemination culture medium. Recently, we analyzed the active ethyl acetate fraction containing high levels of flavonoids. This fraction was further purified by bioassay‐guided separation to isolate isoliquiritigenin and formononetin, which contributed to the improved rate of IVF. Isoliquiritigenin and formononetin may be useful therapeutic agents for infertility treatment.

Keywords

  • in vitro fertilization
  • activator
  • licorice
  • isoliquiritigenin
  • formononetin

1. Introduction

Glycyrrhiza species (Leguminosae), commonly known as licorice, are perennial plants that grow up to 1.5 m high and are distributed in drylands from Western Europe to Russia, and are particularly abundant in China and Mongolia. Licorice mainly consists of dried roots and stolons of G. uralensis Fisch and G. glabra Linne. Therefore, two species are listed in pharmacopoeia worldwide. Licorice is one of the most important crude drugs prescribed with other herb medicines in traditional Chinese medicine (TCM) for the treatment and prophylaxis of sore throats (as an antitussive), coughs and bronchial catarrh (as an expectorant), inflammation, allergic reactions, rheumatism and arthritis, liver disease, tuberculosis and adrenocorticoid insufficiency [15]. Nearly 500 components have been identified in licorice. Among them, glycyrrhizin is controlled at a concentration of more than 2.0% as a standardization marker component because the phamacological properties of licorice might be depend upon glycyrrhizin, and furthermore a flavonoid liquiritin has a quantitative limitation in Japanese pharmacopoeia [1]. Glycyrrhizin is a protein‐kinase inhibitor with anti‐ulcer and anti‐viral activities [6]. In Japan and China, nowadays, glycyrrhizin is used for the treatment of hepatitis [4, 79]. It has been reported that glycyrrhizin has interferon‐inducing activity and anti‐HIV‐1 activity [1012]. Moreover, glycyrrhizin is well known as a natural sweetener and used in food additives and cosmetics [13]. On the other hand, flavonoids have also various pharmacological activities such as anti‐hepatotoxic, anti‐inflammatory, anti‐ulcer, anti‐allergenic and anti‐viral as well as cardioprotective activities [2]. Figure 1 indicates major components in licorice.

Figure 1.

Major components in licorice.

In order to control the quality of licorice, we investigated and succeeded the preparation of monoclonal antibody (MAb) against glycyrrhizin and set up an enzyme‐linked immunosorbent assay (ELISA) as quick, simple and reproducible assay system [14]. Furthermore, a new staining system, eastern blotting was developed [15] and immunoaffinity isolation of glycyrrhizin resulting in glycyrrhizin‐knockout extract, which can be used to survey the real activity of glycyrrhizin in licorice [16, 17]. Regarding flavonoid, anti‐liquiritin MAb [18] and eastern blotting [19] was developed. Since the above knowledge of components in licorice have been accumulated and also Tanaka et al. have been investigating about proteins [2022] and mitochondria [23] related to fertilization using reproducing assay system, we have started to survey in vitro fertilization (IVF) active components in licorice.

Advertisement

2. In vitro fertilization of mouse sperm by licorice crude extract and fraction

Although previous studies have investigated whether licorice can increase pregnancy rates or not, the clear result has not been found yet [24]. However, since it is known that glycyrrhizin acts as the modulator of 11β‐hydroxysteroid dehydrogenase (Type 1 and 2) which are the enzyme related to steroidal hormone [25], a speculation of relationship between licorice and testosterone and/or estrogen comes out. In fact Hajirahimkhan et al. searched three licorice species, G. uralensis, G. glabra and G. inflata, and found that isoliquiritigenin indicated strong estrogen‐like activity, suggesting that this compound may be cyclized to liquiritigenin, which is an active flavonoid, under physiological conditions [26].

The sperm from wild‐type C57BL/6 mice has high capacity for fertilization when cultured in standard medium (e.g., HTF) supplemented with bovine serum albumin for IVF or with polyvinyl alcohol (PVA) and methyl β‐cyclodextrin (MBCD). On the other hand, IVF efficiency using the sperm of aged BALB/cA mice (>48 weeks of age) is low, albeit fluctuated between mice [27]. However, we found that the licorice crude extract improved the fertilizing ability of BALB/cA mouse sperm in vitro as indicated in Figure 2 and that the fertilized eggs developed normally [28]. We performed five separate experiments using five different BALB/cA mice. The fertilization rate for HTF medium containing PVA plus MBCD and licorice extract (0.12 mg/ml) was between 15.6 and 84.0% (average: 43.0 ± 11.0%). On the other hand, the fertilization rate was between 0.0 and 43.5% (average: 15.0 ± 7.8%) when licorice extract‐free medium was used. The optimal concentration of licorice extract in HTF medium was 0.3 mg/ml.

Figure 2.

Influence of licorice extract on the IVF. Sperm from BALB/cA mice was preincubated in conditioned medium with or without licorice extract (0.12 mg/mL). Two‐cell embryos were effectively obtained with preincubation medium containing licorice extract. The extract had a significant effect on IVF (n = 5, P < 0.05).

Park et al. reported that licorice extract increased cyclophosphamide teratogenicity and upregulated the mRNA expression of cytochrome P‐450 2B in rats [29]. The results suggest that licorice root contains various bioactive components. However, they may not affect gene expression because transcription rates in spermatozoa are low [30]. Our findings indicate that components in licorice other than glycyrrhizin, or together other components and glycyrrhizin, can improve the IVF rates without damaging fertilized eggs.

In order to confirm the property of active component in licorice, the crude extract was fractionated with EtOAc and n‐BuOH successively. Figure 3 showed the fertilization level indicated by the percentage of two‐cell embryos describing that the EtOAc fraction was more effective compared to that of n‐BuOH fraction. From this result, active components might be not conjugated compounds like saponins including glycyrrhizin but free compound like flavonoids as indicated in Figure 1 depending on their solubility.

Figure 3.

Active fraction of licorice extract and glycyrrhizin against IVF. n-BuOH (1.6 mg/mL) and EtOAc (1 mg/mL) fractions of licorice and glycyrrhizin (1.6 mg/mL) were added to the conditioned medium. Activity was observed in the EtOAc fraction containing flavonoids.

Advertisement

3. Survey of active components in licorice

The above active EtOAc fraction was bioassay‐guided separated by silica gel column chromatography with a CHCl3‐MeOH solvent system as an eluent to give five fractions (1–5). Fraction 2 was further purified using a reversed‐phase C18 column eluting with MeOH‐H2O to yield active compound 1. Fraction 4 was also purified by the same way of fraction 2 to give active compound 2.

Compound 1 was a yellow powder indicating an ion peak at m/z 257 [M+H]+ in mass spectrometry having strong yellow fluorescence. From these evidences, compound 1 was supposed to be a non‐conjugated flavonoid like a chalcone derivative, which has strong fluorescence in general. Finally, compound 1 was determined to be isoliquiritigenin (Figure 4) [31] by 13C nuclear magnetic resonance (NMR), 1‐dimensional (1D; 1H and 13C) and 2D correlation spectroscopy (COSY), heteronuclear multiple quantum coherence (HMQC) and heteronuclear multiple‐bond coherence (HMBC) spectroscopies.

Figure 4.

The structures of isoliquiritingenin with key COSY (bold lines) and HMBC correlations (dash arrows).

Compound 2 was a pale yellow powder indicating an ion peak at m/z 268 [M+H]+ that the mass fragment pattern resembled to a flavonoid compound having a methoxyl group in a molecule. 13C NMR showed a typical lower‐shifted C‐3 carbon (124.9 m/z) suggesting that compound 2 might be an isoflavone. The spectra of 1H, 13CNMR and 2D (COSY, HMQC and HMBC) confirmed that compound 2 was formononetin [32] (Figure 5).

Figure 5.

The structures of formononetin with key COSY (bold lines) and HMBC correlations (dash arrows).

Advertisement

4. Confirmation of IVF activity for two isolated components

The HTF medium containing PVA and MBCD with isoliquiritigenin or formononetin at a concentration range from 0 to 0.04 mg/ml was tested for IVF [33]. The optimal concentration of isoliquiritigenin was found at 0.02 mg/ml resulting in 47.2 ± 16.8% of IVF ratio. In the case of forononetin, the ratio was slightly higher (50.2 ± 9.5%) but not significantly, than that of isoliquiritigenin as indicated in Figure 6.

Figure 6.

Optimal concentration of licorice extract for IVF. Black and gray bars indicated isoliquiritigenin and formononetin, respectively.

We examined the viability of embryos treated with isoliquiritigenin (Figure 7A) or formononetin (Figure 7B) to confirm that both embryos were morphologically normal similar to the previous observations using licorice crude extract [28].

Figure 7.

Morphology of blastocysts incubated with isoliquiritigenin or formononetin.

Advertisement

5. Licorice in future

It is considered that the decrease of population is now a serious problem in advanced countries depending on diversification of course of life (late marriage, unmarried, etc.). Carlsen et al. reported interesting evidence related to human semen [34]. It became evident that approximately 30% decrease of sperm number during 40 years from 1950 to 1990 occurred. From this data, it suggested that the number of sperm was half in 2005 compared to that in 1950. This evidence may be deeply related to the decrease of population. In order to increase the fertilization ratio, the activation of sperm is necessary against the decrease of sperm number and also the mechanism of increase of IVF by isoliquiritigenin or formononetin should be evident.

We investigated the incorporation and distribution of isoliquiritigenin or formononetin in mice sperm in order to obtain some information related to the mechanism. Figure 8 showed the fluorescence staining in mice sperm using fluorescence microscope. Staining distributed in almost all part of sperm. It seems to be that this phenomenon might be related to activation of sperm although the mechanism is still unknown and should be solved from now.

Figure 8.

Fluorescence imaging of mice sperm in the preincubation medium with isoliquiritigenin (Iso) and formononetin (For). Signals were observed intensely in postacrosomal region (star) and mid piece (arrow).

Licorice used to be used for approximately 70% of TCM formula. From this current status, the pseudohyperaldosteronism often occurred by over uptake of licorice. It is well known that this phenomenon was occurred by taking of much glycyrrhizin. Glycyrrhizin is hydrolyzed to give glycyrrhetic acid (aglycone) by enteric bacteria, resulting the reabsorption of glycyrrhetic acid. This compound is changed to mono glycoside in liver. Glycyrrhetic acid monoglycoside inhibits 11β‐hydroxysteroid dehydrogenase (HSD), which catalyzes the conversion of cortisol to cortisone resulting in the accumulation of cortisol which reacts to aldosterone receptor.

This phenomenon activates the reabsorption of sodium ion, and on the other hand potassium ion is eliminated inducing pseudohyperaldosteronism. Therefore, if we take too much licorice extracts for promotion of fertilization, such disease may be occurred. Previously, we purified glycyrrhizin from the crude extract of licorice using an immunoaffinity column conjugated with anti‐glycyrrhizin monoclonal antibody, and prepared glycyrrhizin‐knockout extract [17]. The glycyrrhizin‐knockout extract contains all components except glycyrrhizin. Thus, glycyrrhizin‐knockout extract can function for promoting fertilization Figure 9.

Figure 9.

The inhibition of 11β‐hydroxsteroid dehydrogenase (HSD) by glycyrrhetic acid monoglycoside inhibits in  liver.

References

  1. 1. Taira Z, Yabe K, Hamaguchi Y, Hirayama K, Kishimoto M, Ishida S, Ueda Y. Effects of Sho‐saiko‐to extract and its components, Baicalin, baicalein, glycyrrhizin and glycyrrhetic acid, on pharmacokinetic behavior of salicylamide in carbon tetrachloride intoxicated rats. Food Chem Toxicol. 2004;42(5):803–807.
  2. 2. Kim SC, Byun SH, Yang CH, Kim CY, Kim JW, Kim SG. Cytoprotective effects of Glycyrrhizae radix extract and its active component liquiritigenin against cadmium‐induced toxicity (effects on bad translocation and cytochrome c‐mediated PARP cleavage). Toxicology. 2004;197(3):239–251.
  3. 3. Fuchikami J, Isohama Y, Sakaguchi M, Matsuda M, Kucota T, Akie YK, Fujino A, Miyata T. Effect of glycyrrhizin on late asthmatic responses induced by antigen inhalation in guinea pigs. J Pharmacol Sci. 2004;94(Suppl.1): 251.
  4. 4. Jakkula M, Boucher TA, Beyendorff U, Conn SM, Johnson JE, Nolan CJ, Peine CJ, Albrecht JH. A randomized trial of Chinese herbal medicines for the treatment of symptomatic hepatitis C. Arch Intern Med. 2004;164(12):1341–1346.
  5. 5. Yanagawa Y, Ogura M, Fujimoto E, Shono S, Okuda E. Effects and cost of glycyrrhizin in the treatment of upper respiratory tract infections in members of the Japanese maritime self‐defense force: preliminary report of a prospective, randomized, double‐blind, controlled, parallel‐group, alternate‐day treatment assignment clinical trial. Curr Ther Res Clin Exp. 2004;65(1):26–33.
  6. 6. Hsiang CY, Lai IL, Chao DC, Ho TY. Differential regulation of activator protein 1 activity by glycyrrhizin. Life Sci. 2002;70(14):1643–1656.
  7. 7. Xu J, Tanaka H, Shoyama Y. One‐step immunochromatographic separation and ELISA quantification of glycyrrhizin from traditional Chinese medicines. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;850(1–2):53–58.
  8. 8. Lian Z, Niwa K, Gao J, Tagami K, Mori H, Tamaya T. Association of cellular apoptosis with anti‐tumor effects of the Chinese herbal complex in endocrine‐resistant cancer cell line. Cancer Detect Prev. 2003;27(2):147–154.
  9. 9. Chung WT, Lee SH, Kim JD, Sung NS, Hwang B, Lee SY, Yu CY, Lee HY. Effect of the extracts from Glycyrrhiza uralensis Fisch on the growth characteristics of human cell lines: anti‐tumor and immune activation activities. Cytotechnology. 2001;37(1):55–64.
  10. 10. Davidson A, Siddell S. Potential for antiviral treatment of severe acute respiratory syndrome. Curr Opin Infect Dis. 2003;16(6):565–571.
  11. 11. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS‐associated coronavirus. Lancet. 2003;361(9374):2045–2046.
  12. 12. Bedoya LM, Palomino SS, Abad MJ, Bermejo P, Alcami J. Screening of selected plant extracts for in vitro inhibitory activity on human immunodeficiency virus. Phytother Res. 2002;16(6):550–554.
  13. 13. Kim NC, Kinghorn AD. Highly sweet compounds of plant origin. Arch Pharm Res. 2002;25(6):725–746.
  14. 14. Tanaka H, Shoyama Y. Formation of a monoclonal antibody against glycyrrhizin and development of an ELISA. Biol Pharm Bull. 1998;21(12):1391–1393.
  15. 15. Shan S, Tanaka H, Shoyama Y. Enzyme‐linked immunosorbent assay for glycyrrhizin using anti‐glycyrrhizin monoclonal antibody and an eastern blotting technique for glucuronides of glycyrrhetic acid. Anal Chem. 2001;73(24):5784–5790.
  16. 16. Uto T, Tuvshintogtokh I, Shoyama Y. Preparation of knockout extract for determination of really active compound using MAb. Curr Drug Discov Technol. 2011;8(1):16–23.
  17. 17. Uto T, Morinaga O, Tanaka H, Shoyama Y. Analysis of the synergistic effect of glycyrrhizin and other constituents in licorice extract on lipopolysaccharide‐induced nitric oxide production using knock‐out extract. Biochem Biophys Res Commun. 2012;417(1):473–478.
  18. 18. Fujii S, Morinaga O, Uto T, Nomura S, Shoyama Y. Development of a monoclonal antibody‐based immunochemical assay for liquiritin and its application to the quality control of licorice products. J Agric Food Chem. 2014;62(15):3377–3383.
  19. 19. Fujii S, Morinaga O, Uto T, Nomura S, Shoyama Y. Development of double eastern blotting for major licorice components, glycyrrhizin and liquiritin for chemical quality control of licorice using anti‐glycyrrhizin and anti‐liquiritin monoclonal antibodies. J Agric Food Chem. 2016;64(5):1087–1093.
  20. 20. Kitamura K, Nishimura H, Nishimune Y, Tanaka H. Identification of human HAPRIN potentially involved in the acrosome reaction. J Androl. 2005;26(4):511–518.
  21. 21. Tanaka H, Iguchi N, Toyama Y, Kitamura K, Takahashi T, Kaseda K, Maekawa M, Nishimune Y. Mice deficient in the axonemal protein Tektin‐t exhibit male infertility and immotile‐cilium syndrome due to impaired inner arm dynein function. Mol Cell Biol. 2004;24(18):7958–7964.
  22. 22. Tokuhiro K, Isotani A, Yokota S, Yano Y, Oshio S, Hirose M, Wada M, Fujita K, Ogawa Y, Okabe M, Nishimune Y, Tanaka H. OAZ‐t/OAZ3 is essential for rigid connection of sperm tails to heads in mouse. PLoS Genet. 2009;5(11):e1000712.
  23. 23. Nakada K, Sato A, Yoshida K, Morita T, Tanaka H, Inoue S, Yonekawa H, Hayashi J, Mitochondria‐related male infertility related to fertilization, PNAS. 2006;103(41) 15148–15153.
  24. 24. Shin S, Jang JY, Choi BI, Baek IJ, Yon JM, Hwang BY, Park D, Jeon JH, Nam SY, Yun YW, Kim YB. Licorice extract does not impair the male reproductive function of rats. Exp Anim. 2008;57(1):11–17.
  25. 25. Yaw HP, Ton SH, Kadir KA. Glycyrrhizic acid as the modulator of 11β‐hydroxysteroid dehydrogenase (type 1 and 2) in rats under different physiological conditions in relation to the metabolic syndrome. J Diabetes Metab. 2015;6:522.
  26. 26. Hajirahimkhan A, Simmler C, Yuan Y, Anderson JR, Chen SN, Nikolić D, Dietz BM, Pauli GF, van Breemen RB, Bolton JL. Evaluation of estrogenic activity of licorice species in comparison with hops used in botanicals for menopausal symptoms. PLoS One. 2013;8(7):e67947.
  27. 27. Vasudevan K, Sztein JM. Treatment of sperm with extracellular adenosine 5'‐triphosphate improves the in vitro fertility rate of inbred and genetically modified mice with low fertility. Theriogenology. 2011;76(4):729–736.
  28. 28. Tung NH, Shoyama Y, Wada M, Tanaka H, Improved in vitro fertilization ability of mouse dperm caused by the addition of licorice extract to the preincubation medium. The Open Reproductive Sci. J. 2014;6:1–7.
  29. 29. Park D, Yang YH, Choi EK, Yang G, Bae DK, Lee SH, Kim TK, Kyung J, Kim D, Choi KC, Kim YB. Licorice extract increases cyclophosphamide teratogenicity by upregulating the expression of cytochrome P‐450 2B mRNA. Birth Defects Res B Dev Reprod Toxicol. 2011;92(6):553–559.
  30. 30. Tanaka H, Baba T. Gene expression in spermiogenesis. Cell Mol Life Sci. 2005;62(3): 344–354.
  31. 31. Fu B, Li H, Wang X, Lee FS, Cui S. Isolation and identification of flavonoids in licorice and a study of their inhibitory effects on tyrosinase. J Agric Food Chem. 2005;53(19):7408–7414.
  32. 32. Yankep E, Fomum ZT, Bisra D, Dagne E, Hellwig V, Steglich W. O‐Geranylated isoflavones and a phenylcoumarin from Millettia griffoniana. Phytochemistry. 1998;49(8):2521–2523.
  33. 33. Tung HN, Shoyama Y, Wada M, Tanaka H, Two activators of in vitro fertilization in mice from licorice. Biochem. Biophys. Res. Commun. 2015;467:447–450.
  34. 34. Carlsen E, Giwercman A, Keiding N, Skakkebaek NE. Evidence for decreasing quality of semen during past 50 years. BMJ. 1992;305(6854):609–613.

Written By

Hiromitsu Tanaka, Morimasa Wada, Nguyen Huu Tung, Shunsuke Fujii, Takuhiro Uto and Yukihiro Shoyama

Submitted: 29 June 2016 Reviewed: 13 October 2016 Published: 03 May 2017